Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Active not recruiting
565 enrolled 16 charts
CRC-DRAW
Active not recruiting
196 enrolled
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Completed
2,310 enrolled
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
Completed
380 enrolled 22 charts
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
Completed
146 enrolled
DECOR-19
Completed
1,051 enrolled
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Completed
803 enrolled
Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab
Completed
200 enrolled
Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200
Completed
350 enrolled
S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304
Completed
220 enrolled
Irinotecan in Treating Patients With Colorectal Cancer
Terminated
28 enrolled
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
Completed
64 enrolled
Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
Completed
744 enrolled